Kim Yeon Ji, Chung Woo Chul, Choi Sooa, Jung Yun Duk, Lee Jaejun, Chae Seung Yun, Jun Kyong Hwa, Chin Hyung Min
Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.
Department of Surgery, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea.
Korean J Gastroenterol. 2017 Apr 25;69(4):220-225. doi: 10.4166/kjg.2017.69.4.220.
BACKGROUND/AIMS: Peritoneal micrometastasis is known to play an important role in the recurrence of gastric cancer. However, its effects remain equivocal. Herein, we examine the messenger RNA (mRNA) as tumor markers, carcinoembryonic antigen (CEA), and cytokeratin 20 (CK20), in peritoneal washing fluid. Moreover, we evaluate whether these results could predict the recurrence of gastric cancer following curative resection.
We prospectively enrolled 132 patients with gastric cancers, who had received an operation, between January 2010 and January 2013. The peritoneal lavage fluid was collected at the operation field and semi-quantitative PCR was performed using the primers for CEA and CK20. We excluded patients with stage IA (n=28) early gastric cancer, positive cytologic examination of peritoneal washings (n=7), and those who were lost during follow up (n=18).
A total of 79 patients with gastric cancers were enrolled, and the mean follow-up period was 39.95±19.25 months (range, 5-72 months). According to the multivariate analysis, T4 stage at the initial diagnosis was significantly associated with recurrence. All cases of recurrence were CEA positive and 6 cases were CK20 positive. The positive and negative predictive values of CEA were 32.0% and 100%, respectively, whereas those of CK20 were 37.5% and 71.4%, respectively. Disease free survival of CK20-negative cases was 36.17±20.28 months and that of CK20-positive cases was 32.06±22.95 months (p=0.39).
It is unlikely that the real time polymerase chain reaction results of mRNA for CEA and CK20 in peritoneal washing fluid can predict recurrence. However, negative results can convince surgeons to perform curative R0 resection.
背景/目的:已知腹膜微转移在胃癌复发中起重要作用。然而,其影响仍不明确。在此,我们检测了腹膜冲洗液中作为肿瘤标志物的信使核糖核酸(mRNA)、癌胚抗原(CEA)和细胞角蛋白20(CK20)。此外,我们评估这些结果是否能够预测胃癌根治性切除术后的复发情况。
我们前瞻性纳入了2010年1月至2013年1月期间接受手术的132例胃癌患者。在手术区域收集腹膜灌洗液,并使用CEA和CK20的引物进行半定量聚合酶链反应。我们排除了IA期(n = 28)早期胃癌患者、腹膜冲洗液细胞学检查阳性患者(n = 7)以及随访期间失访的患者(n = 18)。
共纳入79例胃癌患者,平均随访期为39.95±19.25个月(范围5 - 72个月)。根据多因素分析,初次诊断时的T4期与复发显著相关。所有复发病例CEA均为阳性,6例CK20为阳性。CEA的阳性预测值和阴性预测值分别为32.0%和100%,而CK20的阳性预测值和阴性预测值分别为37.5%和71.4%。CK20阴性病例的无病生存期为36.17±20.28个月,CK20阳性病例的无病生存期为32.06±22.95个月(p = 0.39)。
腹膜冲洗液中CEA和CK20的mRNA实时聚合酶链反应结果不太可能预测复发。然而,阴性结果可使外科医生确信进行根治性R0切除。